Sort
23,748 grants matching “melanoma”
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
$247,249Sean S Park · Mayo Clinic Rochester · R01 · FY2016 · CA
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
$247,249Sean S Park · Mayo Clinic Rochester · R01 · FY2017 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$247,218Fernando Macian · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
'IN VITRO SCREENING OF SELECTED CHEMOPREVENTIVE AGENTS U
$247,187Iit Research Institute · N01 · FY2000 · CN
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
$247,084Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · CA
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
$247,050Tracy L McGaha · University Health Network · R01 · FY2016 · CA
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
$247,050Tracy L McGaha · University Health Network · R01 · FY2017 · CA
Role of HOS in Cell Transformation and Apoptosis
$247,041Serge Y Fuchs · University Of Pennsylvania · R01 · FY2014 · CA
Mechanism of Eliciting Antitumor Cell Immunity Via Lentivector Immunization
$247,003Yukai He · Augusta University · R01 · FY2007 · CA
Protein-Protein Interactions in Melanosome Biogenesis
$246,986University Of Wisconsin Madison · R01 · FY2005 · AR
TCR Engineered CD4 Cells as Helpers in Tumor Immunity
$246,900Bijay Mukherji · University Of Connecticut Sch Of Med/Dnt · R01 · FY2009 · CA
ARF6 function in cancers driven by RAS hyperactivation
$246,879Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2021 · CA
Transcriptional Regulation of Melanocyte Development
$246,814Henry Ford Health System · R01 · FY2003 · AR
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma
$246,805Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R00 · FY2016 · CA
CELL BASED TUMOR VACCINES TARGETING CD4+ T LUMPHOCYTES
$246,764University Of Maryland Balt Co Campus · R01 · FY2001 · CA
Amide Acidity Analysis of Intrinsic and Ligand-induced Flexibility and Allostery
$246,756Griselda Hernandez · Wadsworth Center · R01 · FY2012 · GM
UT M.D. Anderson Cancer Center SPORE in Melanoma
$246,751Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
A quiescent G0-like cell state as a barrier to eradication oral cancer stem cells
$246,736Devraj Basu · University Of Pennsylvania · R21 · FY2014 · DE
Promoting Tumor Immunity by Cross-linking B7-DC
$246,712Larry R Pease · Mayo Clinic Rochester · R01 · FY2009 · CA
Promoting Tumor Immunity by Cross-linking B7-DC
$246,712Larry R Pease · Mayo Clinic Rochester · R01 · FY2010 · CA
Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy
$246,711Jeffrey A. Hubbell · University Of Chicago · R21 · FY2023 · CA
Isolating Circulating Tumor Cells
$246,701Lydia L Sohn · University Of California Berkeley · R21 · FY2016 · CA
Academic Training in Medical Oncology
$246,662University Of California Los Angeles · T32 · FY2002 · CA
MOUSE CORE
$246,637Michael I Nishimura · Loyola University Chicago · P01 · FY2015 · CA
Mechanism of Chaperone-Mediated Tumor Rejection
$246,625Christopher V Nicchitta · Duke University · R01 · FY2006 · CA